Voyager Therapeutics Balance Sheet - Quarterly (NASDAQ:VYGR)

Add to My Stocks
$22.5 $1.33 (6.28%) VYGR stock closing price Jun 21, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Voyager Therapeutics, and helps in stock analysis. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Voyager Therapeutics stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Voyager Therapeutics balance sheet as at the end of 2018 Q1 indicates an asset turnover ratio of 0.02 and debt to equity ratio of 0. Also check Voyager Therapeutics revenue and Voyager Therapeutics operating cash flow for the same period.

View and download Voyager Therapeutics quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Cash140.37M31.53M48.2M66.3M43.6M36.64M63.5M67.03M33.89M31.3M
Marketable Securities77.82M137.52M77.38M75.02M114.06M137.77M127.64M136.96M170.09M163.02M
Receivables----------
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets2.43M2.73M2.6M3.4M3.41M4.36M1.86M1.48M1.7M1.55M
Total Current Assets
220.63M171.79M128.19M144.72M161.08M178.78M193.02M205.47M205.69M195.89M
Property Plant & Equipment-13.27M---9.28M---4.01M
Accumulated Depreciation-2.99M---1.39M----
Net Property Plant & Equipment
11.45M10.28M10.55M10.67M10.13M7.89M4.25M3.6M3.55M3.23M
Investment & Advances1.32M1.1M-1.48M2M1.36M2.41M-9.98M30M
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets1.61M1.3M1.2M1.53M1.87M1.52M2.29M---
Total Assets
235.02M184.47M140.91M158.41M175.09M189.56M201.98M209.81M219.98M229.45M
Notes Payable----2.92M-----
Accounts Payable1.37M1.02M------1.69M-
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses9.35M11.49M10.49M7.31M5.59M6.48M6.3M5.04M2.66M3.43M
Income Taxes Payable----------
Other Current Liabilities20.21M3.38M9.53M4.21M4.91M6.76M12.29M14.25M18.71M19.88M
Total Current Liabilities
30.94M15.89M20.94M11.83M11.06M13.8M19.38M19.76M23.07M23.93M
Mortgages----------
Deferred Taxes/Income104.78M33.51M33.75M40.26M40.3M39.81M33.44M34.31M33.26M36.4M
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities1M1.01M1.01M1.01M1.02M-----
Total Liabilities
136.73M50.42M55.7M53.12M52.39M53.64M52.86M54.11M56.38M60.38M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus299.11M295.01M234.51M230.77M229M225.96M223.81M221.96M220.55M219.12M
Retained Earnings-200.68M-160.71M-148.88M-125.53M-106.66M-90.01M-75.34M-66.34M-57.01M-49.82M
Treasury Stock----------
Other Liabilities-0.16M-0.28M-0.45M---0.05M----0.25M
Shareholders Equity98.29M134.05M85.2M105.29M122.69M135.92M149.12M155.7M163.59M169.07M
Total Liabilities & Shareholders Equity235.02M184.47M140.91M158.41M175.09M189.56M201.98M209.81M219.98M229.45M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest Voyager Therapeutics stock price, and Voyager Therapeutics historical stock prices show the stock price movement over time, and the Voyager Therapeutics PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Voyager Therapeutics owns and has monetary significance. VYGR assets grew from $184.47M in 2017 Q4 to $235.02M in 2018 Q1. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Voyager Therapeutics is $136.73M. Shareholders equity comes under liabilities as it is money the company owes the holders of VYGR stock.

Voyager Therapeutics Balance Sheet - Key Ratios

Current ratio
7.13
Debt to equity ratio
0
Asset turnover ratio
0.02
Receivables turnover
0
Price to book ratio
6.16